BIONTECH SE - AMERICAN DEPOSITARY SHARES

Pfizer and BioNTech Confirm High Efficacy and No Serious Safety Concerns Through Up to Six Months Following Second Dose in Updated Topline Analysis of Landmark COVID-19 Vaccine Study

01 Apr 2021 05:45:00 By Nasdaq GlobeNewswire

Pfizer-BioNTech Announce Positive Topline Results of Pivotal COVID-19 Vaccine Study in Adolescents

31 Mar 2021 05:45:00 By Nasdaq GlobeNewswire

BioNTech Announces Full Year 2020 Financial Results and Corporate Update

30 Mar 2021 05:30:00 By Nasdaq GlobeNewswire

BioNTech provides Update on Vaccine Production Status at Marburg Manufacturing Site

26 Mar 2021 08:45:00 By Nasdaq GlobeNewswire

EMA Approves New Storage Option for Pfizer-BioNTech Vaccine, Easing Distribution and Storage of Doses Across European Union

26 Mar 2021 08:20:00 By Nasdaq GlobeNewswire

BioNTech to Report Full Year Financial Results for 2020 and Provide Corporate Update on the Fourth Quarter on March 30, 2021

23 Mar 2021 06:00:00 By Nasdaq GlobeNewswire

Real-World Evidence Confirms High Effectiveness of Pfizer-BioNTech COVID-19 Vaccine and Profound Public Health Impact of Vaccination One Year After Pandemic Declared

11 Mar 2021 05:45:00 By Nasdaq GlobeNewswire

Pfizer and BioNTech Initiate a Study as Part of Broad Development Plan to Evaluate COVID-19 Booster and New Vaccine Variants

25 Feb 2021 05:45:00 By Nasdaq GlobeNewswire

Pfizer and BioNTech Submit COVID-19 Vaccine Stability Data at Standard Freezer Temperature to the U.S. FDA

19 Feb 2021 06:07:06 By Nasdaq GlobeNewswire

Pfizer and BioNTech Commence Global Clinical Trial to Evaluate COVID-19 Vaccine in Pregnant Women

18 Feb 2021 12:30:00 By Nasdaq GlobeNewswire